Buprenorphine Hydrochloride Tablets Market

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Buprenorphine Hydrochloride Tablets Market contains market size and forecasts of Buprenorphine Hydrochloride Tablets in global, including the following market information:
Global Buprenorphine Hydrochloride Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Buprenorphine Hydrochloride Tablets Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Buprenorphine Hydrochloride Tablets companies in 2021 (%)
The global Buprenorphine Hydrochloride Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.5mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Buprenorphine Hydrochloride Tablets include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Buprenorphine Hydrochloride Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Buprenorphine Hydrochloride Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, by Type, 2021 (%)
0.5mg
2mg
Global Buprenorphine Hydrochloride Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, by Application, 2021 (%)
Analgesic
Opioid Antagonist
Global Buprenorphine Hydrochloride Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Buprenorphine Hydrochloride Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Buprenorphine Hydrochloride Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Buprenorphine Hydrochloride Tablets revenues share in global market, 2021 (%)
Key companies Buprenorphine Hydrochloride Tablets sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Buprenorphine Hydrochloride Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Teva